Waheed Sangrar

Waheed Sangrar is an Adjunct Assistant Professor in the Department of Pathology and Molecular Medicine at Queen's University School of Medicine. His research focuses on molecular oncology, particularly tyrosine kinase signaling in cancer development and therapeutic targeting. His work employs systems biology approaches to identify combination therapies for breast cancer.

Research interests include Fer tyrosine kinase function, Ras-MAPK signaling pathways, and targeted inhibition strategies in triple-negative breast cancer models. His publications demonstrate expertise in preclinical cancer model systems and computational analysis of signaling networks.